HOUSE 4134118th CongressReferred to the Subcommittee on Health.

Updated Drug Labeling for Patient Safety Act

Last Action: 6/16/2023

Actions

2023-06-16Referred to the Subcommittee on Health.
2023-06-14Referred to the House Committee on Energy and Commerce.
2023-06-14Introduced in House
2023-06-14Introduced in House

CRS Summary

As of 2023-06-14 (00)

Updated Drug Labeling for Patient Safety Act

This bill allows generic drug manufacturers to revise labels with updated safety information that differs from the referenced brand-name drug.

Cosponsors (3)

Ann Kuster (D-NH)
Nanette Barragan (D-CA)
Paul Tonko (D-NY)

Subjects

Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Prescription drugs

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.